Towards Healthcare
Biologics Market Size to Project USD 1009.33 Billion by 2035

Biologics Market to Double by 2035 Rising Demand for Advanced Therapies

According to market projections, the biologics sector is expected to grow from USD 485.19 billion in 2025 to USD 1009.33 billion by 2035, reflecting a CAGR of 7.6%. Biologics are advanced medicines made from living cells or organisms. They include vaccines, gene therapies, and monoclonal antibodies used to treat diseases like cancer, autoimmune disorders, and rare conditions. Biologics offer targeted, effective treatments but can be complex and costly to produce.

Last Updated : 23 December 2025 Category: Biotechnology Insight Code: 5108 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Biologics Market Assessment

  • Overview
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Biologics Market Assessment

  • Overview
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Europe Biologics Market Assessment

  • Overview
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Asia Pacific Biologics Market Assessment

  • Overview
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Latin America Biologics Market Assessment

  • Overview
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Middle East and Africa Biologics Market Assessment

  • Overview
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Company Profiles

  • Amgen
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Merck & Co.
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb
  • Sanofi
  • Bayer AG
  • AstraZeneca
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Eli Lilly and Company

Conclusion & Recommendations

FAQ's

Answer : The biologics market is projected to grow from USD 522.06 billion in 2026 to USD 1009.33 billion by 2035, expanding at a CAGR of 7.6% due to rising chronic diseases and technological advancements.

Answer : North America dominated the biologics market in 2024 due to strong biopharma infrastructure, while Asia-Pacific is expected to witness the fastest growth driven by expanding manufacturing capacity and biosimilar adoption.

Answer : Monoclonal antibodies dominated the market in 2024 due to their high specificity, longer half-life, fewer side effects, and increasing FDA approvals.

Answer : Food and Drug Administration, World Health Organization, American Cancer Society, ASCO.gov., National Institute of Biologics, CDSCO.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar